+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
2557-49-5,MFCD00200358
Catalog No.:AA00ILN3

2557-49-5 | Diflorasone

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
95%
in stock  
$43.00   $30.00
- +
25mg
95%
in stock  
$86.00   $60.00
- +
100mg
97%
in stock  
$230.00   $161.00
- +
250mg
97%
in stock  
$347.00   $243.00
- +
1g
97%
in stock  
$879.00   $615.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00ILN3
Chemical Name:
Diflorasone
CAS Number:
2557-49-5
Molecular Formula:
C22H28F2O5
Molecular Weight:
410.4515
MDL Number:
MFCD00200358
SMILES:
OCC(=O)[C@@]1(O)[C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)C1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F
Properties
Computed Properties
 
Complexity:
839  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
9  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.9  

Literature

Title: Structures from powders: diflorasone diacetate.

Journal: Steroids 20090101

Title: Non-steroidal and steroidal anti-inflammatory drugs vary in their modulation of dendritic cell function in the elicitation phase of allergic contact dermatitis.

Journal: Experimental dermatology 20060401

Title: Cutaneous reactions to imatinib mesylate treated by topical steroid.

Journal: American journal of hematology 20050301

Title: TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis. Effects of cilomilast and diflorasone diacetate on T-cell-attracting chemokines.

Journal: The British journal of dermatology 20041001

Title: A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy.

Journal: International journal of dermatology 20010701

Title: Wickrema Sinha AJ, et al. Percutaneous absorption and excretion of tritium-labeled diflorasone diacetate, a new topical corticosteroid in the rat, monkey and man. J Invest Dermatol. 1978 Dec;71(6):372-7.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 2557-49-5
1879-77-2

1879-77-2

 1880-61-1

1880-61-1

 50-02-2

50-02-2

 426-13-1

426-13-1

 338-95-4

338-95-4

 127-31-1

127-31-1
Building Blocks
More >
Historical Records
1187966-95-5

1187966-95-5
Tags:2557-49-5 Molecular Formula|2557-49-5 MDL|2557-49-5 SMILES|2557-49-5 Diflorasone
Catalog No.: AA00ILN3
2557-49-5,MFCD00200358
2557-49-5 | Diflorasone
Pack Size： 5mg
Purity： 95%
in stock
$43.00 $30.00
Pack Size： 25mg
Purity： 95%
in stock
$86.00 $60.00
Pack Size： 100mg
Purity： 97%
in stock
$230.00 $161.00
Pack Size： 250mg
Purity： 97%
in stock
$347.00 $243.00
Pack Size： 1g
Purity： 97%
in stock
$879.00 $615.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00ILN3
Chemical Name: Diflorasone
CAS Number: 2557-49-5
Molecular Formula: C22H28F2O5
Molecular Weight: 410.4515
MDL Number: MFCD00200358
SMILES: OCC(=O)[C@@]1(O)[C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)C1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F
Properties
Complexity: 839  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 9  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 29  
Hydrogen Bond Acceptor Count: 7  
Hydrogen Bond Donor Count: 3  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.9  
Literature fold

Title: Structures from powders: diflorasone diacetate.

Journal: Steroids20090101

Title: Non-steroidal and steroidal anti-inflammatory drugs vary in their modulation of dendritic cell function in the elicitation phase of allergic contact dermatitis.

Journal: Experimental dermatology20060401

Title: Cutaneous reactions to imatinib mesylate treated by topical steroid.

Journal: American journal of hematology20050301

Title: TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis. Effects of cilomilast and diflorasone diacetate on T-cell-attracting chemokines.

Journal: The British journal of dermatology20041001

Title: A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy.

Journal: International journal of dermatology20010701

Title: Wickrema Sinha AJ, et al. Percutaneous absorption and excretion of tritium-labeled diflorasone diacetate, a new topical corticosteroid in the rat, monkey and man. J Invest Dermatol. 1978 Dec;71(6):372-7.

Related Products of of 2557-49-5
1879-77-2
1879-77-2
1880-61-1
1880-61-1
50-02-2
50-02-2
426-13-1
426-13-1
338-95-4
338-95-4
127-31-1
127-31-1
Building Blocks More >
952604-26-1
952604-26-1
1-Bromo-4-(4-bromophenyl)naphthalene
AA00IMAO | MFCD30478554
1420042-07-4
1420042-07-4
2,4-Dibromo-6-[(e)-[[(1r,2r)-2-(isoindolin-2-yl)-1,2-diphenylethyl]imino]methyl]phenol
AA00IMDM | MFCD30725749
180403-03-6
180403-03-6
(Pyridin-4-ylmethyl)phosphonic Acid Monohydrate
AA00IMH8 | MFCD31618150
1956355-82-0
1956355-82-0
Methyl 4-methyl-7-nitro-1h-indole-2-carboxylate
AA00IMK6 | MFCD27922872
245039-28-5
245039-28-5
2-[(1E)-(methoxyimino)methyl]-N,N'-diphenylpropanediamide
AA00IMP8 | MFCD00140376
118630-19-6
118630-19-6
5-(4-phenylpiperazin-1-yl)-1H-1,2,4-triazol-3-amine
AA00IMRY | MFCD00138991
245039-50-3
245039-50-3
2-[(1E)-(methoxyimino)methyl]-N,N'-bis[3-(trifluoromethyl)phenyl]propanediamide
AA00IMV7 | MFCD00140383
477845-27-5
477845-27-5
5-(3-chlorothiophen-2-yl)-2-[4-(4-fluorophenyl)piperazin-1-yl]-1H-pyrrole-3-carbonitrile
AA00IMXM | MFCD00794200
341967-66-6
341967-66-6
(2-chloro-1,3-thiazol-5-yl)methyl 3-(trifluoromethyl)benzoate
AA00IN0Y | MFCD01568170
685108-27-4
685108-27-4
1,3-dimethyl 2-[(3-chlorophenyl)methyl]-2-(4-nitrophenyl)propanedioate
AA00IN3L | MFCD03617550
Historical Records
1187966-95-5
1187966-95-5
Submit
© 2017 AA BLOCKS, INC. All rights reserved.